BIOQULE
DEAD

Serial Number

76221547

Owner

Mermaid Pharmaceuticals GmbH

Attorney

Talivaldis Cepuritis

Filing Date

Mar 8, 2001

Add to watchlist:

No watchlists yet
View on USPTO

BIOQULE Trademark

Serial Number: 76221547

BIOQULE is a trademark filed by Mermaid Pharmaceuticals GmbH on March 8, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Mermaid Pharmaceuticals GmbH (12 trademarks)

Lagerstr. 11
20357 Hamburg , DE

Entity Type: 03

Trademark Details

Filing Date

March 8, 2001

Registration Date

Not Registered

Published for Opposition

December 31, 2002

Goods & Services

PHARMACEUTICAL PREPARATIONS FOR USE IN THE DIAGNOSIS AND TREATMENT OF HUMAN DISEASES AND DISORDERS, NAMELY, CIRCULATORY, RESPIRATORY, ENDOCRINE, NEUROLOGIC, CARDIOVASCULAR, ALIMENTARY, ONCOLOGIC, AUTO-IMMUNE OR IMMUNE-RELATED, PULMONARY, MUSCULOSKELETAL, LYMPHATIC, GASTROINTESTINAL, BONE, SENSORY, VIRAL, URINARY, RENAL, INFECTIOUS, METABOLIC AND CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS; DIAGNOSTIC ASSAYS AND TEST KITS COMPRISED OF REAGENTS FOR CLINICAL AND MEDICAL LABORATORY USE TO DIAGNOSE, PROGNOSE, PREDICT AND TREAT DISEASES AND FOR PROVIDING GENOMIC AND PROTEOMIC PROFILES USEFUL IN THE SELECTION OF THERAPEUTICS; ASSAYS AND TEST KITS COMPRISED OF REAGENTS FOR EVALUATING EFFICACY OF TREATMENTS AND TREATMENT PROGRESS; PROGNOSTIC TEST KITS COMPRISED OF REAGENTS FOR IDENTIFYING HEREDITARY RISK FACTORS; DIAGNOSTIC PREPARATIONS, NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES, AND ANTIBODIES, AND MOLECULAR ARRAYS OF BIOLOGICAL MATERIALS FOR CLINICAL OR MEDICAL LABORATORY USE; DIAGNOSTIC PREPARATIONS FOR CLINICAL OR MEDICAL LABORATORY USE

DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE; DIAGNOSTIC PREPARATIONS, NAMELY, PREPARATIONS OF EXTRACTS, ASSAYS, NUCLEIC ACIDS, PROTEINS, POLYPEPTIDES, AND ANTIBODIES, AND MOLECULAR ARRAYS OF BIOLOGICAL MATERIALS FOR SCIENTIFIC OR RESEARCH USE

RESEARCH AND DEVELOPMENT SERVICES RENDERED TO OTHERS FOR DISCOVERING SMALL-MOLECULE DRUGS, ANTIBODIES, ANTISENSE DRUGS, PEPTIDES, PROTEINS AND GENE THERAPY DRUGS; MEDICAL AND DIAGNOSTIC SERVICES, NAMELY, DIAGNOSING, PREVENTING, AND PREDICTING DISEASE, IDENTIFYING HEREDITARY RISK FACTORS, DIAGNOSTIC TESTING, PROGNOSTIC TESTING, GENE AND PROTEIN TESTING, IDENTIFYING PHYSIOLOGICAL CHARACTERISTICS, ESTABLISHING INDIVIDUAL PREVENTATIVE PROGRAMS, ESTABLISHING DISEASE TREATMENTS BASED ON GENE AND PROTEIN EXPRESSION AND ACTIVITY, EVALUATING CLINICAL TRIAL PROGRESS, DRUG MONITORING AND COMPUTER TRACKING OF A PATIENT'S HEALTH PROGRESS

Filing History

ABANDONMENT - NO USE STATEMENT FILED
Nov 6, 2003 ABN6
NOA MAILED - SOU REQUIRED FROM APPLICANT
Mar 25, 2003 NOAM
PUBLISHED FOR OPPOSITION
Dec 31, 2002 PUBO
NOTICE OF PUBLICATION
Dec 11, 2002 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 15, 2002 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2002 CRFA
PAPER RECEIVED
Sep 13, 2002 MAIL
NON-FINAL ACTION MAILED
Apr 4, 2002 CNRT
ASSIGNED TO EXAMINER
Mar 28, 2002 DOCK
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 7, 2002 CRFA
NON-FINAL ACTION MAILED
Jul 3, 2001 CNRT
ASSIGNED TO EXAMINER
Jun 28, 2001 DOCK